AOD9604 5MG — Targeted Fat Oxidation by Dragon Pharma
Optimize your metabolic efficiency with AOD9604, a precision-engineered peptide designed for targeted fat reduction. Unlike traditional growth hormone treatments that may increase hunger or disrupt blood sugar, AOD9604 focuses on lipolysis, making it an ideal choice for those seeking weight management without the appetite-stimulating side effects of GHRPs.
Specifications
| Active Substance | Anti-Obesity Drug-9604 |
| Form | 1 vial x 5 mg |
| Manufacturer | Dragon Pharma |
Description
AOD9604, also known as Tyr-hGH Frag 176-191, is a specialized peptide derived from a modified form of Human Growth Hormone. This specific sequence focuses on the 176-191 amino acid fragment, designed to stimulate the release of fat from cells through a process known as lipolysis.
The primary advantage of AOD9s4 is its ability to target adipose tissue—specifically abdominal fat stores—without the adverse effects on blood sugar or tissue growth typically associated with full-length HGH. It works by activating fat oxidation (burning) and inhibiting lipogenesis (the formation of new fat), all while maintaining a stable metabolic environment.
Extensive research, including laboratory studies on humans and rodents, suggests that AOD9604 possesses high safety and tolerability. Because it does not trigger increased hunger or elevated cortisol levels, it is a highly professional choice for users who want to avoid the "rebound" hunger often seen with other peptide regimens. Furthermore, it shows significant promise for regenerative purposes, particularly when paired with BPC 157 for cartilage and bone repair.
Shipping & Delivery
Please note the following shipping information:
- Temporary shipping restrictions apply to Hawaii and Alaska.
- Military addresses (including APO, FPO, etc.) are currently not supported.
FAQ
Does AOD9604 increase appetite?
No, unlike GHRPs, AOD9604 does not increase hunger or raise cortisol levels, making it easier to maintain a caloric deficit.
How does AOD9604 affect blood sugar?
AOD9604 has been shown to have no negative effect on carbohydrate metabolism or blood sugar levels, providing a safer profile than full-length HGH.
What is the mechanism of action?
AOD9604 activates the degradation and oxidation of fat cells, specifically targeting obese fat cells more effectively than lean ones, without affecting growth or tissue expansion.)